Tuesday, March 22, 2016
Aerin Medical Raises $16.7M For Medical Device
Austin-based Aerin Medical, a developer of non-invasive, medical devies designed to treat nasal breathing disorders using RF energy, said today that it has raised $16.7M in a Series C funding round. The funding was split between a $6.1M in an initial close from Targeted Technology Fund, plus a $10.6M second close from KCK Group. Targeted Technology's Peter Savas and KCK's Nael Kassar both join the company's board with the funding. Aerin Medical has offices in both Austin, Texas as well as Sunnyvale, California, and is led by CEO Fred Dinger.